MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248 | -77.6% | 1,700 | -64.6% | 0.00% | -80.0% |
| Q2 2023 | $1,108 | -66.1% | 4,800 | -64.4% | 0.01% | 0.0% |
| Q1 2023 | $3,270 | +1309.5% | 13,500 | +1587.5% | 0.01% | +400.0% |
| Q4 2022 | $232 | -99.7% | 800 | -38.5% | 0.00% | – |
| Q3 2022 | $84,000 | -9.7% | 1,300 | 0.0% | 0.00% | – |
| Q2 2022 | $93,000 | -26.8% | 1,300 | 0.0% | 0.00% | – |
| Q1 2022 | $127,000 | +15.5% | 1,300 | 0.0% | 0.00% | – |
| Q4 2021 | $110,000 | +6.8% | 1,300 | 0.0% | 0.00% | – |
| Q3 2021 | $103,000 | -79.2% | 1,300 | -74.5% | 0.00% | -100.0% |
| Q2 2021 | $496,000 | -9.7% | 5,100 | +8.5% | 0.00% | 0.0% |
| Q1 2021 | $549,000 | -3.0% | 4,700 | -7.8% | 0.00% | 0.0% |
| Q4 2020 | $566,000 | +5045.5% | 5,100 | +5000.0% | 0.00% | – |
| Q3 2020 | $11,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $11,000 | -96.7% | 100 | -96.7% | 0.00% | -100.0% |
| Q4 2018 | $338,000 | -58.4% | 3,000 | -21.1% | 0.00% | -50.0% |
| Q3 2018 | $813,000 | -23.4% | 3,800 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $1,062,000 | +46.7% | 3,800 | -38.7% | 0.01% | +66.7% |
| Q1 2018 | $724,000 | +92.6% | 6,200 | +51.2% | 0.00% | +50.0% |
| Q4 2017 | $376,000 | +609.4% | 4,100 | +241.7% | 0.00% | – |
| Q3 2017 | $53,000 | +178.9% | 1,200 | 0.0% | 0.00% | – |
| Q2 2017 | $19,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |